Predictive value of positron emission tomography/computed tomography to assess early treatment response to dual human epidermal growth factor receptor 2 (HER2) blockade without chemotherapy for HER2-positive metastatic breast cancer: Are we ready to embrace this "early metabolic look" strategy? Journal Article


Authors: Jhaveri, K.; Ulaner, G. A.; Dickler, M. N.
Article Title: Predictive value of positron emission tomography/computed tomography to assess early treatment response to dual human epidermal growth factor receptor 2 (HER2) blockade without chemotherapy for HER2-positive metastatic breast cancer: Are we ready to embrace this "early metabolic look" strategy?
Keywords: treatment response; overall survival; disease course; cancer recurrence; cancer combination chemotherapy; drug efficacy; outcome assessment; metabolism; progression free survival; editorial; fluorodeoxyglucose f 18; computer assisted emission tomography; trastuzumab; breast metastasis; lapatinib; predictive value; pertuzumab; trastuzumab emtansine; human; priority journal
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 24
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-08-20
Start Page: 2591
End Page: 2593
Language: English
DOI: 10.1200/jco.2015.62.3082
PROVIDER: scopus
PUBMED: 26195716
DOI/URL:
Notes: Export Date: 2 October 2015 -- Source: Scopus
Altmetric Score
MSK Authors
  1. Gary Ulaner
    84 Ulaner
  2. Maura N Dickler
    237 Dickler
  3. Komal Lachhman Jhaveri
    44 Jhaveri